Group 1 pulmonary hypertension (or pulmonary arterial hypertension) is a rare, highly complex, and progressive disorder that is incurable and ultimately can lead to premature death. PAH causes ...

Emerging evidence suggests that arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of vascular and metabolic diseases from a young age. Emerging evidence ...

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA pressure ...

For patients with acute ischemic stroke due to a large-vessel occlusion (LVO), administering intra-arterial thrombolytics after successful endovascular thrombectomy does not significantly improve ...

DKA is a complication of diabetes that can cause many symptoms. Various lab tests can confirm a diagnosis of DKA. These include ABG tests, which measure different components of the blood. In this ...

Kyle Wandashin and Wade Turner are continuing to impress the young entrepreneurship world. Their company, Arterial, has only taken massive strides since their last edition in the Entrepreneurship ...

Just a month after trial results appeared to dampen prospects for the use of intra-arterial thrombolysis on top of stroke thrombectomy in patients with large-vessel occlusions (LVOs), two new trials ...

Objective Arterial stiffness is an early and detectable marker of vascular changes leading to atherosclerotic cardiovascular disease (ACVD). Our objective was to compare the effectiveness of different ...

Pulmonary arterial hypertension is characterized by pulmonary vascular remodeling, cellular proliferation, and poor long-term outcomes. Dysfunctional bone morphogenetic protein pathway signaling is ...